Divi's Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Divi's Laboratories has a total shareholder equity of ₹137.2B and total debt of ₹50.0M, which brings its debt-to-equity ratio to 0.04%. Its total assets and total liabilities are ₹155.9B and ₹18.7B respectively. Divi's Laboratories's EBIT is ₹21.8B making its interest coverage ratio -7.3. It has cash and short-term investments of ₹36.0B.
Key information
0.04%
Debt to equity ratio
₹50.00m
Debt
| Interest coverage ratio | -7.3x |
| Cash | ₹36.02b |
| Equity | ₹137.17b |
| Total liabilities | ₹18.69b |
| Total assets | ₹155.86b |
Recent financial health updates
No updates
Recent updates
Revenues Not Telling The Story For Divi's Laboratories Limited (NSE:DIVISLAB)
Sep 06
Earnings Miss: Divi's Laboratories Limited Missed EPS By 9.1% And Analysts Are Revising Their Forecasts
Aug 06The Divi's Laboratories Limited (NSE:DIVISLAB) Yearly Results Are Out And Analysts Have Published New Forecasts
Jul 19Shareholders Should Be Pleased With Divi's Laboratories Limited's (NSE:DIVISLAB) Price
Apr 19Divi's Laboratories Limited (NSE:DIVISLAB) Not Flying Under The Radar
Dec 27Divi's Laboratories (NSE:DIVISLAB) Will Pay A Dividend Of ₹30.00
Aug 04Divi's Laboratories (NSE:DIVISLAB) Will Pay A Dividend Of ₹30.00
Jul 20Divi's Laboratories (NSE:DIVISLAB) Has Announced A Dividend Of ₹30.00
Jul 06Is Now The Time To Put Divi's Laboratories (NSE:DIVISLAB) On Your Watchlist?
Nov 08Divi's Laboratories (NSE:DIVISLAB) Is Increasing Its Dividend To ₹30.00
Aug 04Divi's Laboratories' (NSE:DIVISLAB) Shareholders Will Receive A Bigger Dividend Than Last Year
Jul 21Divi's Laboratories (NSE:DIVISLAB) Will Pay A Larger Dividend Than Last Year At ₹30.00
Jul 07Here's Why We Think Divi's Laboratories (NSE:DIVISLAB) Might Deserve Your Attention Today
Jul 03Does Divi's Laboratories (NSE:DIVISLAB) Deserve A Spot On Your Watchlist?
Apr 03Should You Be Adding Divi's Laboratories (NSE:DIVISLAB) To Your Watchlist Today?
Dec 23With EPS Growth And More, Divi's Laboratories (NSE:DIVISLAB) Is Interesting
Sep 02Financial Position Analysis
Short Term Liabilities: DIVISLAB's short term assets (₹93.4B) exceed its short term liabilities (₹12.9B).
Long Term Liabilities: DIVISLAB's short term assets (₹93.4B) exceed its long term liabilities (₹5.8B).
Debt to Equity History and Analysis
Debt Level: DIVISLAB has more cash than its total debt.
Reducing Debt: DIVISLAB's debt to equity ratio has reduced from 0.2% to 0.04% over the past 5 years.
Debt Coverage: DIVISLAB's debt is well covered by operating cash flow (32960%).
Interest Coverage: DIVISLAB earns more interest than it pays, so coverage of interest payments is not a concern.